{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:28:08Z","timestamp":1784561288326,"version":"3.55.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ijmmb.2025.100833","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T22:08:53Z","timestamp":1743545333000},"page":"100833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Omadacycline as a promising tetracycline alternative for treating community-acquired bacterial pneumonia: Indian experience"],"prefix":"10.1016","volume":"55","author":[{"given":"Yamuna Devi","family":"Bakthavatchalam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuvasri","family":"Manokaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjan","family":"Adhiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamini","family":"Walia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Veeraraghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10303","key":"10.1016\/j.ijmmb.2025.100833_bib1","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(21)00630-9","article-title":"Community-acquired pneumonia","volume":"398","author":"Aliberti","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ijmmb.2025.100833_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/14787210.2023.2174100","article-title":"Omadacycline in treating community-based infections: a review and expert perspective","volume":"21","author":"Sakoulas","year":"2023","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijmmb.2025.100833_bib3","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2217\/fmb-2020-0182","article-title":"Omadacycline: a therapeutic review of use in community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections","volume":"15","author":"Chopra","year":"2020","journal-title":"Future Microbiol"},{"key":"10.1016\/j.ijmmb.2025.100833_bib4","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2217\/fmb-2016-0100","article-title":"Omadacycline: development of a novel aminomethylcycline antibiotic for treating drug-resistant bacterial infections","volume":"11","author":"Villano","year":"2016","journal-title":"Future Microbiol"},{"issue":"Suppl 1","key":"10.1016\/j.ijmmb.2025.100833_bib5","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1093\/cid\/ciz395","article-title":"Microbiology and preclinical review of omadacycline","volume":"69","author":"Karlowsky","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijmmb.2025.100833_bib6","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","year":"2018"},{"key":"10.1016\/j.ijmmb.2025.100833_bib7","series-title":"Performance standards for antimicrobial testing, CLSI supplement M100","year":"2023"},{"key":"10.1016\/j.ijmmb.2025.100833_bib8","unstructured":"Clinical and Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. CLSI M45, third ed., Clinical and Laboratory Standards Institute, Wayne, PA."},{"issue":"4","key":"10.1016\/j.ijmmb.2025.100833_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02327-17","article-title":"Surveillance of omadacycline activity tested against clinical isolates from the United States and Europe as part of the 2016 SENTRY antimicrobial surveillance program","volume":"62","author":"Pfaller","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijmmb.2025.100833_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1225710","article-title":"Omadacycline in the treatment of community-acquired bacterial pneumonia in patients with comorbidities: a post-hoc analysis of the phase 3 OPTIC trial","volume":"10","author":"Rodriguez","year":"2023","journal-title":"Front Med"},{"issue":"8","key":"10.1016\/j.ijmmb.2025.100833_bib12","first-page":"952","article-title":"Real-world effectiveness of omadacycline and impact of unapproved omadacycline prescription claims among adult outpatients with community-acquired bacterial pneumonia or acute bacterial skin and skin structure infections","volume":"29","author":"Lodise","year":"2023","journal-title":"J Manag Care Spec Pharm"},{"issue":"Suppl 1","key":"10.1016\/j.ijmmb.2025.100833_bib13","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/cid\/ciz396","article-title":"Omadacycline for acute bacterial skin and skin structure infections","volume":"69","author":"Abrahamian","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ijmmb.2025.100833_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/ph12020063","article-title":"Omadacycline: a newly approved antibacterial from the class of tetracyclines","volume":"12","author":"Dur\u00e3es","year":"2019","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.ijmmb.2025.100833_bib15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40265-020-01257-4","article-title":"Omadacycline: a novel oral and intravenous aminomethylcycline antibiotic agent","volume":"80","author":"Zhanel","year":"2020","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.ijmmb.2025.100833_bib16","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S1473-3099(19)30275-0","article-title":"Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial","volume":"19","author":"O'Riordan","year":"2019","journal-title":"Lancet Infect Dis"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085725000465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085725000465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T15:48:40Z","timestamp":1749916120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085725000465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":15,"alternative-id":["S0255085725000465"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmmb.2025.100833","relation":{},"ISSN":["0255-0857"],"issn-type":[{"value":"0255-0857","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omadacycline as a promising tetracycline alternative for treating community-acquired bacterial pneumonia: Indian experience","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmmb.2025.100833","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100833"}}